Africa AIDS relief
Trade and Development Act of 2000 (HR 434) conference report passes House May 4 without earlier amendments to make AIDS drugs more affordable to Sub-Saharan African countries. Senate Judiciary Committee Chairman Hatch (R-Utah) requested in April that House/Senate conferees drop the drug language from the final bill
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth